New indications for pacing

Current Cardiology Reports

Volumn 5, Issue 5, 2003, Pages 369-374

  Willems, Rik ^b   Gillis, Anne M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DOPPLER ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; QUALITY OF LIFE; REVIEW; SINUS NODE DISEASE; STROKE; SUPRAVENTRICULAR PREMATURE BEAT; SYNCOPE; TREATMENT INDICATION; CONTROLLED CLINICAL TRIAL; HEART PACING; RANDOMIZED CONTROLLED TRIAL;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SYNCOPE, VASOVAGAL;

EID: 0642315358     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0093-1     Document Type: Review

References (28)

1. Gillis AM: Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol 2003, in press.
2. Connolly SJ, Kerr CR, Gent M, et al., for the CTOPP Investigators: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000, 342:1385-1391.
3. Kerr CR, Connolly S, Roberts RS, et al.: Effect of pacing mode on cardiovascular death and stroke. The Canadian Trial of Physiologic Pacing: Long Term Follow-up. PACE 2002, 25:II-553.
4. Lamas GA, Lee KL, Sweeney MO, et al.: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002, 346:1854-1862.
5. Toff WD: UK PACE trial. Presented at the American College of Cardiology Scientific Sessions. Chicago: March 30-April 2, 2003.
6. Tang AS, Roberts RS, Kerr C, et al.: Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 2001, 103:3081-3085.
7. Newman D, Lau C, Tang AS, et al.: Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. Am Heart J 2003, 145:430-437.
8. Wilkoff BL, Cook JR, Epstein AE, et al.: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115-3123.
9. Leon AR, Hellkamp AS, Marinchak RA, et al.: Dual chamber pacing for sinus node dysfunction decreases the likelihood of progression to chronic atrial fibrillation after incidence of atrial fibrillation. PACE 2002, 24:714.
10. Mabo P, Funck R, De Roy L, et al.: Impact of ventricular pacing on atrial fibrillation prevention. PACE 2002, 24:II-621.
11. Carlson MD, John Ip, Messenger J, et al., for the ADOPT-A Investigators: A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003, in press.
12. Padeletti L, Purerfellner H, Adler S, et al.: Atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial fibrillation: ASPECT study results. PACE 2002, 24:687.
13. Lee MA, Weachter R, Pollak S, et al., for the ATTEST Investigators: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003, 41:1926-1932.
14. Gillis AM, Unterberg-Buchwald C, Schmidinger H, et al., for the GEM III AT Worldwide Investigators: Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002, 40:1653-1659.
15. Connolly SJ, Sheldon RS, Thorpe KE, et al., on behalf of the VPS II investigators. The Second Vasovagal Pacemaker Study (VPSII): A double-blind randomized controlled trial of pacemaker therapy for the prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA 2003, 289:2224-2229.
16. Gras D, Leclercq C, Tang AS, et al.: Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002, 4:311-320.
17. Auricchio A, Stellbrink C, Sack S, et al.: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002, 39:2026-2033.
18. Linde C, Leclercq C, Rex S, et al.: Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111-118.
19. Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
20. Bradley DJ, Bradley EA, Baughman KL, et al.: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003, 289:730-740.
21. Bristow M: COMPANION trial. Presented at the American College of Cardiology Scientific Sessions. Chicago: March 30-April 2, 2003.
22. Sackner-Bernstein JD: How big a risk is the strategy of biventricular pacing for heart failure? Circulation 2002, 106:II-380-II-381.
23. St John Sutton MG, Plappert TJ, Hilpisch KE, Chinchoy E: Baseline aortic pre-ejection interval (bAPEI) as a predictor of response to cardiac resynchronization therapy (CRT). Circulation 2002, 106:II-380.
24. Adamson PB, St John Sutton MG: Echo-definied ventricular dysynchrony predicts magnitude of response to cardiac resynchronization. Circulation 2002, 106:II-381.
25. Yu CM, Chau E, Sanderson JE, et al.: Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002, 105:438-445.
26. Sogaard P, Egeblad H, Kim WY, et al.: Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002, 40:723-730.
27. Reuter S, Garrigue S, Barold SS, et al.: Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002, 89:346-350.
28. Sogaard P, Egeblad H, Pedersen AK, et al.: Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 2002, 106:2078-2084.